17β-HSD14 Activators

17β-HSD14 include a variety of compounds, primarily involved in the steroidogenesis pathway. Estradiol, a potent estrogen, can enhance the activity of 17β-HSD14 by binding to estrogen receptors, which can lead to an upsurge in the enzymatic conversion of estrone to estradiol, a reaction that 17β-HSD14 can catalyze. Similarly, testosterone and androstenedione, both androgens, serve as direct substrates for 17β-HSD14, increasing its activity by offering more substrate for the conversion process that 17β-HSD14 facilitates. This is an essential step in the biosynthesis of androgens, and by providing an abundance of substrate, 17β-HSD14's enzymatic action is bolstered. Pregnenolone and dehydroepiandrosterone (DHEA) also contribute to this process; pregnenolone by supplying substrates for downstream steroidogenic enzymes leading to an increased production of precursors for 17β-HSD14, and DHEA by acting directly as a substrate that 17β-HSD14 converts to androstenediol.

17β-HSD14 is further influenced by several aromatase inhibitors, including fadrozole, letrozole, exemestane, testolactone, anastrozole, formestane, and vorozole. These compounds inhibit the conversion of androgens into estrogens, consequently increasing the levels of testosterone and other 17β-HSD14 substrates. By preventing the aromatization process, these inhibitors ensure that more testosterone remains available for 17β-HSD14 to act upon, thereby activating the enzyme's function. The elevation of testosterone levels due to the inhibition of aromatase indirectly facilitates the increased enzymatic activity of 17β-HSD14 as it works to maintain the balance of steroid hormones by converting available substrates into their respective active forms. Each of these chemicals, by influencing the levels of substrates or the balance of steroid hormones within the body, can activate 17β-HSD14, ensuring its role in steroid metabolism is efficiently carried out.